Previous Article | Next Article ![]()
Infection and Immunity, May 2007, p. 2626-2629, Vol. 75, No. 5
0019-9567/07/$08.00+0 doi:10.1128/IAI.01599-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Marianela Espina,1,
David S. Moore,2
Wendy L. Picking,1 and
William D. Picking1*
Department of Molecular Biosciences,1 KU Center for Research, Inc., University of Kansas, Lawrence, Kansas 660452
Received 3 October 2006/ Returned for modification 22 November 2006/ Accepted 30 January 2007
|
|
|---|
|
|
|---|
IpaB and IpaD colocalize on the S. flexneri surface in the presence of DOC. IpaD and IpaB were detected on the Shigella surface by using immunofluorescence microscopy as previously described (6). S. flexneri was grown to early log phase in TSB supplemented with 2.5 mM (0.1%, wt/vol) deoxycholate (DOC), a concentration well within the physiological range seen in the human intestine (Fig. 1) (5). As expected, IpaD continued to be detected on the bacterial surface by using rabbit anti-IpaD antiserum and Alexa Fluor 568 goat anti-rabbit immunoglobulin G (IgG) under these conditions (Fig. 1A). In the presence of DOC, however, IpaB was also detected on the Shigella surface by using rabbit anti-IpaB antiserum (Fig. 1B). Both proteins gave rise to similar punctate staining patterns. In contrast, IpaB was not surface exposed in either an mxiH-null (Fig. 1C) or an ipaD-null (Fig. 1D) mutant strain, indicating that IpaB surface localization relies upon a functional TTSS needle and IpaD. The maintenance of IpaD at the Shigella surface appears to be required for IpaB recruitment in the presence of DOC because a small C-terminal deletion that allows IpaD and IpaB secretion without concomitant retention of IpaD at the bacterial surface fails to permit IpaB labeling on the bacterial surface (Table 1).
![]() View larger version (30K): [in a new window] |
FIG. 1. IpaD and IpaB localize to the S. flexneri surface. IpaD and IpaB were detected on the surface of S. flexneri grown in TSB containing 2.5 mM DOC by confocal immunofluorescence microscopy using rabbit anti-IpaD antiserum (A) or rabbit anti-IpaB antiserum (B). IpaB was not detected on the surface of mxiH (C)- or ipaD (D)-null strains. Panels E to H are differential interference contrast (DIC) micrographs of panels A to D, respectively. IpaD and IpaB appeared to colocalize on the S. flexneri surface by double labeling. Panel I shows the DIC micrograph of panels J to L. Panel J is a green pseudocolored image indicating IpaD staining by using anti-IpaD monoclonal antibody. Panel K is a red pseudocolored image indicating IpaB staining by using rabbit anti-IpaB antiserum. Panel L is a merged image of panels J and K. The arrows point to regions where both IpaD and IpaB appear to be labeled.
|
|
View this table: [in a new window] |
TABLE 1. IpaB recruitment to the TTSS needle tip of mutant S. flexneri strainsa
|
To determine whether IpaD and IpaB actually colocalize on the Shigella surface, bacteria were double labeled with anti-IpaD monoclonal antibody and rabbit anti-IpaB antiserum. Primary antibodies were detected using Alexa Fluor 488 goat anti-mouse IgG (Fig. 1J) and Alexa Fluor 568 goat anti-rabbit IgG (Fig. 1K). When the images were merged (Fig. 1L), IpaD and IpaB appeared to colocalize. While IpaD could be readily observed without IpaB costaining, IpaB was not typically observed on the surface without colocalizing with at least some population of IpaD (Fig. 1, panels J to L). The fact that a short C-terminal truncation of IpaD eliminated its association with the Shigella surface (Table 1) but allowed uncontrolled secretion of IpaD and IpaB indicated that none of the observed results are due to the readsorption of secreted IpaD, IpaB, or IpaD/IpaB complexes to the bacterial surface. These findings prompted a closer look at the localization of IpaB and IpaD with respect to the Shigella TTSA.
IpaB and IpaD colocalize at the S. flexneri TTSA needle tip. Bacteria and sheared MxiH needles were examined by transmission electron microscopy with negative staining and immunogold labeling. Shigella was grown to early log phase in TSB containing 2.5 mM DOC. The bacteria or needles sheared from the bacteria were applied to carbon-Formvar grids and treated with monoclonal anti-IpaD IgG, followed by 5-nm gold particle-labeled goat anti-mouse F(ab')2 and rabbit anti-IpaB antiserum and 20-nm gold particle-labeled goat anti-rabbit IgG (Fig. 2). The grids were then stained with 2% uranyl acetate and imaged using a Jeol 1200 EX II transmission electron microscope at an electron acceleration voltage of 120 keV as described previously (6). In Fig. 2A and B, needles sheared from the bacterial surface show IpaD labeling (5-nm gold particles) near the needle tip with IpaB labeling (20-nm gold particles) associated with the same needle. Similar micrographs showing bacterium-associated needles indicated that the observed staining was at the needle tip and not at the base of sheared needles (Fig. 2C).
![]() View larger version (142K): [in a new window] |
FIG. 2. Transmission electron micrographs of immunogold-labeled IpaD and IpaB at the S. flexneri TTSA needle tip. Free TTSA needles (A, B, E, and F) or S. flexneri-associated needles (C, D, and G) were immunolabeled with secondary gold-labeled IgG or F(ab')2 fragments and negatively stained as described in the text. Typical dissociated needles are shown in panels A and B after being double labeled for IpaD (5-nm gold particles) and IpaB (20-nm gold particles), respectively. In panel C, a bacterium-associated needle is labeled for IpaD with 5-nm gold particles and for IpaB with 20-nm gold particles. A Shigella-associated needle (D) and a needle dissociated from Shigella (E) (another needle with neither end exposed crosses the field) are shown after being stained with anti-IpaB IgG only following exposure to DOC. A needle dissociated from Shigella (F) is shown after being stained with anti-IpaD only following exposure to DOC. In panel G, a Shigella-associated needle stained for IpaB after the bacteria were grown without any exposure to DOC is shown. Although needle breakage could account for the lack of IpaB detection, no IpaB staining was found to be associated with needles from multiple samples.
|
DOC promotes maturation to a secretion-competent state. The small amphipathic dye Congo red (CR) is known to induce a burst of Shigella type III secretion which mimics that seen upon host cell contact (1). DOC causes a minor, low-level increase in type III secretion during sustained growth (12), but whether it induces a rapid burst of secretion has not been explored. Thus, early-log-phase bacteria were resuspended in phosphate-buffered saline containing 35 µg/ml CR or 2.5 mM DOC for 30 min. The supernatants were then collected, and the levels of IpaB, IpaC, and IpaD were determined by immunoblot analysis using monoclonal anti-IpaB, anti-IpaC, and anti-IpaD antibodies followed by IRDye 800 goat anti-mouse secondary antibodies. Immunoblots were visualized using an Odyssey infrared imager (LI-COR, Lincoln, NE). Unlike CR, DOC does not induce the burst of secretion associated with TTSS activation (Fig. 3). CR and DOC therefore seem to influence the TTSS differently. Because DOC does not actually induce a rapid burst of type III secretion, it is unlikely that IpaB localization at the needle tip is an artifact of the secretion process. The molecular basis for DOC-mediated recruitment of IpaB to the Shigella TTSA needle tip remains to be determined. We speculate that DOC association with IpaD results in a conformational change that allows IpaB to exit the TTSA and remain bound to IpaD at the needle tip in the absence of further secretion stimuli.
![]() View larger version (77K): [in a new window] |
FIG. 3. Analysis of protein secretion by S. flexneri. IpaB, IpaC, and IpaD from the supernatants of equal numbers of S. flexneri following 30 min of incubation in phosphate-buffered saline containing 35 µg/ml CR or 2.5 mM DOC were analyzed by immunoblotting using monoclonal anti-IpaB, anti-IpaC, and anti-IpaD antibodies and IRDye 800 goat anti-mouse IgG.
|
Funding was provided by grants AI034428 and AI057927 to W.D.P. and by grant NIH39334 and the KU Center for Research, Inc., to the Microscopy and Analytical Imaging Laboratory.
Published ahead of print on 12 February 2007. ![]()
Current address: Department of Pediatrics, Duke University, Durham, NC. ![]()
Current address: Infection, Immunity, Injury and Repair Program, The Hospital for Sick Children, University of Toronto, Toronto, Canada. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»